ACRS
Aclaris Therapeutics Inc
Price:  
1.36 
USD
Volume:  
712,545.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aclaris Fair Value

-549.90 %
Upside

What is the fair value of Aclaris?

As of 2025-04-29, the Fair Value of Aclaris Therapeutics Inc (ACRS) is -6.12 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.36 USD, the upside of Aclaris Therapeutics Inc is -549.90%.

Is Aclaris a good investment?

With the market price of 1.36 USD and our fair value calculation, Aclaris Therapeutics Inc (ACRS) is not a good investment. Investing in Aclaris stocks now will result in a potential loss of 549.90%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.36 USD
Stock Price
-6.12 USD
Fair Price
FAIR VALUE CALCULATION

Aclaris Fair Value

Peter Lynch's formula is:

Aclaris Fair Value
= Earnings Growth Rate x TTM EPS
Aclaris Fair Value
= 5.00 x -1.22
Aclaris Fair Value
= -6.12

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -51.02 -90.87 -86.91 -88.48 -132.06 -89.87
YoY growth 68.38% -78.11% 4.36% -1.81% -49.26% -11.29%

Aclaris Fair Value - Key Data

Market Cap (mil) 146.77
P/E
Forward P/E
EPS -1.22
Avg earnings growth rate -11.29%
TTM earnings -132.06